Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.63 |
| ▸ | LMNA | P02545 | 4/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | HTT | P42858 | 4/20 | 0.61 |
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | STAT3 | P40763 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.55 |
| ▸ | RELA | Q04206 | 1/20 | 0.55 |
| ▸ | SLC9A1 | P19634 | 2/20 | 0.54 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | DRD2 | P14416 | 1/20 | 0.52 |
| ▸ | DRD4 | P21917 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9853294 | 1.00 | TDP1 (0.68) | TDP1SMN1; SMN2LMNAALOX15TSHR | |
| SCHEMBL3868979 | 1.00 | TDP1 (0.68) | TDP1SMN1; SMN2LMNAALOX15TSHR | |
| SCHEMBL595111 | 1.00 | TDP1 (0.68) | TDP1SMN1; SMN2LMNAALOX15TSHR | |
| SCHEMBL9038339 | 1.00 | TDP1 (0.68) | TDP1SMN1; SMN2LMNAALOX15TSHR | |
| SCHEMBL6321085 | 1.00 | TDP1 (0.68) | TDP1SMN1; SMN2LMNAALOX15TSHR | |
| SCHEMBL11408718 | 1.00 | TDP1 (0.68) | TDP1SMN1; SMN2LMNAALOX15TSHR | |
| SCHEMBL9853336 | 1.00 | TDP1 (0.68) | TDP1SMN1; SMN2LMNAALOX15TSHR | |
| SCHEMBL4888041 | 1.00 | TDP1 (0.68) | TDP1SMN1; SMN2LMNAALOX15TSHR | |
| SCHEMBL16097150 | 1.00 | TDP1 (0.68) | TDP1SMN1; SMN2LMNAALOX15TSHR | |
| SCHEMBL9853222 | 1.00 | TDP1 (0.68) | TDP1SMN1; SMN2LMNAALOX15TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0262343-B1 | N-alkylated quaternary nitrogen-containing heterocycles, process for their preparation and their use in pharmaceutical compositions | PUETTER MEDICE CHEM PHARM (DE) | 1996-01-03 | — | — | EP | claimed |
| WO-2024181373-A1 | METHOD FOR SELECTIVELY MODIFYING SUBSTRATE SURFACE, METHOD FOR PRODUCING SURFACE-TREATED SUBSTRATE, AND COMPOSITION | JSR株式会社 | 2024-09-06 | — | — | WO | disclosed |
| US-10752648-B2 | Magnetic ionic liquids, methods of making and uses thereof as solvents in the extraction and preservation of nucleic acids | THE UNIVERSITY OF TOLEDO (US) | 2020-08-25 | — | — | US | disclosed |
| US-20190194643-A1 | Magnetic Ionic Liquids, Methods of Making and Uses Thereof as Solvents in the Extraction and Preservation of Nucleic Acids | THE UNIVERSITY OF TOLEDO (US) | 2019-06-27 | — | — | US | disclosed |
| US-10280416-B1 | Magnetic ionic liquids, methods of making and uses thereof as solvents in the extraction and preservation of nucleic acids | THE UNIVERSITY OF TOLEDO (US) | 2019-05-07 | — | — | US | disclosed |
| CN-108360085-A | Anti-oxidant fiber of a kind of polyphenylene sulfide based on laminar nano particle and preparation method thereof | 安徽工程大学 | 2018-08-03 | — | — | CN | disclosed |
| CN-106832931-A | A kind of exfoliated polyphenylene sulfide/Nano composite material of montmorillonite and preparation method thereof | 江南大学 | 2017-06-13 | — | — | CN | disclosed |
| EP-0262343-B1 | N-alkylated quaternary nitrogen-containing heterocycles, process for their preparation and their use in pharmaceutical compositions | PUETTER MEDICE CHEM PHARM (DE) | 1996-01-03 | — | — | EP | disclosed |
| US-5133973-A | Quaternary Ammonium Cationic Surfactants, Antimetabolites | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1992-07-28 | — | — | US | disclosed |
| US-5118808-A | Pharmaceutical preparations | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1992-06-02 | — | — | US | disclosed |
| US-5051435-A | Micelles of triazolium compounds as cationic surfactants | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1991-09-24 | — | — | US | disclosed |
| US-5045530-A | Conprising a micelle or a vesicle of a cationic teniside based on a hydrophobic alkyl-substituted pyridinium compound and a hydrophobic drug; drug delivery; skin disorders | MEDICI CHEM.-PHARM. FABRIK PUTTER GMBH (DE) | 1991-09-03 | — | — | US | disclosed |
| US-4999435-A | Cationic Surfactants, Drugs, Immunoassay | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1991-03-12 | — | — | US | disclosed |
| US-4965357-A | CATIONIC TENSIDES, ANTIMETABOLITES | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1990-10-23 | — | — | US | disclosed |
| US-4894454-A | BACTERICIDES | MEDICE CHEM.-PHARM. FABRIK, PUTTER GMBH & CO., KG (DE) | 1990-01-16 | — | — | US | disclosed |
| US-4882435-A | CATIONIC TENSIDES; THIADIAZOLIUM SALTS | MEDICE CHEM.-PHARM. FABRIK (DE) | 1989-11-21 | — | — | US | disclosed |
| US-4877883-A | CATIONIC SURFACTANTS | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1989-10-31 | — | — | US | disclosed |
| US-4874850-A | CATIONIC TENSIDES IN MICELLES WITH HYDROPHOBIC PEPTIDES; DRUG DELIVERY | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. (DE) | 1989-10-17 | — | — | US | disclosed |
| US-4870174-A | CATIONIC SURFACTANTS, SMALL CRITICAL MICELLE CONCENTRATIONS | MEDICE CHEM.-PHARM. FABRIK (DE) | 1989-09-26 | — | — | US | disclosed |
| US-4460709-A | Process for producing oxygen-containing organic compounds | AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY (JP) | 1984-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10752648-B2 | Magnetic ionic liquids, methods of making and uses thereof as solvents in the extraction and preservation of nucleic acids | POLRMT, HNRNPH3, HNRNPL | TDP1 382/4885SMN1; SMN2 113/4885LMNA 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.